Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis

Clinical trial NCT01039597 · UNKNOWN

Trial details

NCT number: NCT01039597
Sponsor: Ore Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Mild to Moderate Ulcerative Colitis

Start date: 2009-12-01
Primary completion: 2011-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.